CAXTON ASSOCIATES LP – Viking Therapeutics, Inc. Transaction History
CAXTON ASSOCIATES LP portfolio value:
$547,000
portfolio value
CAXTON ASSOCIATES LP quarter portfolio value change:
-5.88%
quarter
Viking Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -31.54% | -92.61K shares | -302K | $2.72 | 201.03K |
| Q2 2022 | share | Increase | +203.76% | 196.97K shares | 559K | $2.89 | 293.64K |
| Q1 2022 | share | Increase | +422.38% | 78.16K shares | 205K | $3 | 96.67K |
| Q4 2021 | share | 0.00% | 0 shares | -31K | $4.64 | 18.50K | |
| Q3 2021 | share | Decrease | -42.00% | -13.40K shares | -75K | $6.28 | 18.50K |
| Q2 2021 | share | Decrease | -17.66% | -6.84K shares | -54K | $5.99 | 31.90K |
| Q1 2021 | share | Increase | +94.71% | 18.84K shares | 133K | $6.33 | 38.75K |
| Q4 2020 | share | Increase | 0.00% | 19.90K shares | 112K | $5.63 | 19.90K |